Par Pharmaceutical Companies (PRX)
Par Pharmaceutical Companies Beneish M-Score: -3.057
View PRX Beneish M-Score with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
PRX Beneish M-Score Rankings
| Overall | 76th percentile | 886 of 3771 |
| Sector | 85th percentile | 50 of 343 in Healthcare |
| Industry | 88th percentile | 1 of 9 in Drugs - Generic |
PRX Beneish M-Score Range, Past 5 Years
| Minimum | -3.209 | Dec 2010 |
| Maximum | -1.390 | Dec 2009 |
| Average | -2.573 |
About Beneish M Score
The Beneish M Score helps to uncover companies who are likely to be manipulating their reported earnings. Companies with a higher score are more likely to be manipulators. This is a probabilistic model, so it will not detect manipulators with 100% accuracy.
The best cut-off point depends on the costs mistakenly classifying in one of two ways:
1) Classifying firm that is manipulating earnings as a non-manipulator (Type I error), and
2) Classifying a firm as a manipulator when it actually was not manipulating (Type II Error).
Here are optimal cut-offs according to Beneish, presented as the score followed by the cost of Type I error relative to cost of Type II error):
M Score HTML Table:
| Score | Relative Error Costs (Type I:Type II) |
|---|---|
| M Score > -1.49 | (10:1) | M Score > -1.78 | (20:1) | M Score > -1.89 | (40+:1) |
Beneish excluded financial institutions from his sample when calculating the M-Score, so extreme care should be taken when looking at M-Scores of financial firms - their business models are different from the manufacturing and other service firms that Beneish used in his study.
If you want more details, here is the original Beneish M Score Paper, or you can learn about our calculation by clicking "Learn More" below.
Learn More
You may also be interested in these PRX related companies
PRX News
Barclays Cuts Estimates on Par Pharmaceutical (PRX); Removing Lovaza Contribution From Model
May 31, 2:11PM Street Insider
May 31, 2:11PM Street Insider
Teva Pharmaceutical Inds, VeriFone Systems Among Stocks Down on Above-average Volume Tuesday
May 29, 4:34PM Fox Business
May 29, 4:34PM Fox Business
$PRX Mentioned more than normal on StockTwits - Currently at 8 x average daily social activity
about 2 days ago by TradeIdeasQuant
about 2 days ago by TradeIdeasQuant
$AMRN up following news that $Teva and $PRX lost a bid to sell the generic form of $GSK Lovaza. http://stks.co/41F0
about 2 days ago by abubnic
about 2 days ago by abubnic
Teva (TEVA), Par Pharma (NPRX) said to lose bid to sell the generic form of Glaxo's (GSK) Lovaza
May 29, 3:20PM Street Insider
May 29, 3:20PM Street Insider
RT @TraderRadar $AAPL $NFLX $PRX Keep these on your radar for higher prices next week// $NFLX based on what evidence??
about 6 days ago by lipong23
about 6 days ago by lipong23
$AAPL $NFLX $PRX Keep these on your radar for higher prices next week
about 6 days ago by TraderRadar
about 6 days ago by TraderRadar
@TraderRadar Like $PRX - should keep moving after pull back to $39 area
about 6 days ago by OMillionaires
about 6 days ago by OMillionaires
UBS Maintains a 'Buy' on Par Pharmaceutical (PRX); Comments From Conference Call
May 09, 12:21PM Street Insider
May 09, 12:21PM Street Insider
Listen to $PRX Q1 2012 earnings call - live at 09:00 AM, ondemand after - http://stks.co/3iVK
about 23 days ago by earningscast
about 23 days ago by earningscast
Also sold my $HMSY on weakness. Picked up shares of $PRX Friday. Any thoughts?
about 40 days ago by robertfreedland
about 40 days ago by robertfreedland
Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Healthy Deal with Handa
Apr 20, 9:46AM Street Insider
Apr 20, 9:46AM Street Insider
Par Pharmaceutical Acquires Rights to Market and Distribute Generic Dexilant® in the U.S.
Apr 19, 3:05PM Benzinga
Apr 19, 3:05PM Benzinga
Par Pharmaceutical Companies to Report First Quarter 2012 Results on May 8, 2012
Apr 09, 9:00AM PR Newswire
Apr 09, 9:00AM PR Newswire
$PRX is 5.0% up since open on unusual high volume and 5.5% up since close.
about 56 days ago by TradeBot
about 56 days ago by TradeBot
$WCG $CL $SJM $PRX Hit 52-Week Highs http://stks.co/39sz My story via @TheStreet #52WeekHigh
about 62 days ago by azendrian
about 62 days ago by azendrian
$PRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/39RA
about 62 days ago by MarketBrief
about 62 days ago by MarketBrief
Horizon Pharma (HZNP) Files Patent Infringement Suit Against Par Pharma (PRX) Over DUEXIS Tabs
Mar 28, 4:30PM Street Insider
Mar 28, 4:30PM Street Insider
$PRX forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/33Pn
about 69 days ago by RecogniaEvents
about 69 days ago by RecogniaEvents
Impressive development programs, partnerships and product launch prep make IntelGenX look like a solid bet at these prices
Mar 23, 8:34AM Thomson Reuters ONE
Mar 23, 8:34AM Thomson Reuters ONE
$PRX forms bearish "Triple Top" chart pattern. http://stks.co/2epQ
about 90 days ago by RecogniaEvents
about 90 days ago by RecogniaEvents
Listen to $PRX Q4 2011 earnings call - live at 09:00 AM, ondemand after - http://stks.co/2af5
about 93 days ago by earningscast
about 93 days ago by earningscast
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PRX | 35.84 | -1.17 | -3.16% | 1.353B |
| PRWTD | 1.51 | -0.04 | -2.58% | |
| PRWT | 1.51 | -0.04 | -2.58% | 15.15M |
| PRU | 46.45 | -0.20 | -0.43% | 21.92B |
| PLL | 55.65 | -0.76 | -1.35% | 6.510B |
| PLG | 1.19 | -0.01 | -0.83% | 213.11M |
| PLFE | 8.84 | +0.04 | +0.45% | 260.30M |
| PLD | 32.00 | +0.21 | +0.66% | 14.62B |
| PLCM | 11.45 | -0.13 | -1.12% | 2.055B |
| PATR | 20.39 | -0.73 | -3.46% | 189.83M |
